Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Derivative Settlement
  • Contact Us

Events & Presentations

Upcoming Events
More events are coming soon.
Corporate Presentation
03.23.2023
Iveric Bio Corporate Overview March 2023
11.04.2022
The Efficacy of Avacincaptad Pegol in Geographic Atrophy: GATHER1 and GATHER2 Results
11.04.2022
Safety of Intravitreal Avacincaptad Pegol in Geographic Atrophy: GATHER1 and GATHER2 Results
09.30.2022
GATHER2 Pivotal Phase 3 Study Results: Efficacy of Intravitreal Avacincaptad Pegol in Geographic Atrophy
09.30.2022
GATHER2 Pivotal Phase 3 Study Results: Safety of Intravitreal Avacincaptad Pegol in Geographic Atrophy
Archived Events
06.18.2021
Dry AMD: A Virtual Symposium for Investors and Analysts
Register here
06.18.2021
Dry Age-Related Macular Degeneration Virtual Symposium
Listen to Webcast

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap